Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 7/20 | 0.43 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.41 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 3/20 | 0.41 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.39 |
| ▸ | SLC22A12 | Q96S37 | 10/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | SLC22A11 | Q9NSA0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24617028 | 0.88 | AR (0.45) | ARIMPDH2IMPDH1PGRAAK1 | |
| SCHEMBL2669999 | 0.80 | IMPDH2 (0.52) | ARIMPDH2IMPDH1SLC22A12SLC22A6 | |
| SCHEMBL24617123 | 0.80 | KIF11 (0.49) | ARIMPDH2IMPDH1SLC22A12SLC22A6 | |
| SCHEMBL15853169 | 0.79 | MCL1 (0.46) | ARPGRCYP11B1CYP11B2 | |
| SCHEMBL24617498 | 0.79 | IMPDH2 (0.41) | ARIMPDH2IMPDH1SLC22A12SLC22A6 | |
| SCHEMBL24617018 | 0.78 | KIF11 (0.51) | ARIMPDH2IMPDH1SLC22A12SLC22A6 | |
| SCHEMBL15853171 | 0.77 | AR (0.51) | ARPGRCYP11B1CYP11B2 | |
| SCHEMBL23625545 | 0.76 | AR (0.43) | ARIMPDH2IMPDH1PGRCYP11B1 | |
| SCHEMBL23624587 | 0.74 | AR (0.48) | ARIMPDH2IMPDH1PGRCYP11B1 | |
| SCHEMBL6152302 | 0.74 | IMPDH2 (0.49) | ARIMPDH2IMPDH1SLC22A12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220220084-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220220084-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC APPARATUS | EXOC4, CYBA, SCO2 | AR 4279/4885IMPDH2 3476/4885IMPDH1 4064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.